Announcements Trials

Browse Landscape

Phase

Phase 2 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 3 Xanthomatosis, Cerebrotendinous 1 Recurrence 1 Oligodendroglioma 1 Melanoma 1 Medulloblastoma 1 Influenza, Human 1 Glioma 1 Diffuse Intrinsic Pontine Glioma 1

Interventions

Temozolomide 15 Filgrastim 13 Cyclophosphamide 9 Carboplatin 9 Granulocyte Colony-Stimulating Factor 7 Etoposide 7 Thiotepa 5 Peripheral Blood Stem Cell Transplantation 5 Melphalan 5 Vorinostat 4 Busulfan 4 sonidegib 3 ribociclib 3 Vincristine 3 Topotecan 3 O(6)-benzylguanine 3 Magnetic Resonance Spectroscopy 3 Irinotecan 3 Automobiles 3 veliparib 2 sargramostim 2 pembrolizumab 2 fludarabine 2 etoposide phosphate 2 Valproic Acid 2 Thalidomide 2 Surgical Procedures, Operative 2 Stem Cell Transplantation 2 Specimen Handling 2 Radiotherapy, Intensity-Modulated 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Medulloblastoma × Diphtheria-Tetanus Vaccine × Clear all

NCT06514898 2026-04-03

MATCHPOINT

University of Florida

Phase 1 Active not recruiting

Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡